MITRO Biotech Co., Ltd. is the first molecular imaging contract research organization (MI-CRO) company in China. By applying advanced radiolabeling and in vivo molecular imaging techniques, MITRO provides domestic and overseas customers with integrated new drug development solutions and outsourcing contract research services, covering drug screening, bio-distribution, pharmacokinetics and pharmacodynamics. MITRO offers translational research on different subjects, from nude mice, rats, monkeys to humans. MITRO is dedicated to exploring disease mechanisms, developing drugs for diagnosis and treatment, and evaluating therapeutic effects by focusing on major diseases (includingtumor, coronary heart disease, Alzheimer's disease, Parkinson's disease, epilepsy and rheumatic and immunological diseases)andresearch frontiers (includingreceptor, gene expression and stem cell research).